 |
Plaquex® Oral |
| CONTENTS |
Plaquex® Oral gelcaps
contain the following ingredients per serving: Serving size:2 capsules |
| 520 mg Soy Lecithin, 61 % Phosphatides | |
| Other ingredients: Gelatin, Vegetable Glycerin, Purified Water | |
| INDICATIONS |
Plaquex® Oral gelcaps are for the following indications:
|
| - Hypercholesterolaemia | |
| - Hyperlipoproteinaemia | |
| - Liver Disease | |
| - Suboptimal
Blood Rheology
|
|
|
Plaquex®
Oral lowers LDL and triglycerides and increases HDL. It also improves blood
flow and liver function. It’s main ingredient is phosphatidylcholine.
Phosphatidylcholine is the building block of cell membranes and transport
vessels for blood lipids. The action of EPL in many studies was reflected in
an increase of HDL cholesterol and a decrease in LDL cholesterol, VLDL
triglycerides as well as reduced ratio of LDL/HDL cholesterol. The main
reason being that the transport vessels had an increased capacity for LDL
and HDL up take in their cell membranes. The administration of
phosphatidylcholine also results in a decrease in aortic lipid peroxidation
products, but also in an increase in glutathione levels in the liver, plasma
and aortic tissue. The glutathione-dependent antioxidative capacity in the
aortic wall was found to increase markedly. Plaquex Oral is indicated for
lowering cholesterol levels, triglyceride levels and to improve liver
function but also as a additional treatment to Plaquex infusions to prevent
reformation of plaque in the blood vessels after removal.
|
|
| Study summaries on Plaquex® Oral | |
|
|
|
| To order, go to www.biorica.biz, click on "heart care" or use the following orderform: | |
| Plaquex Oral Orderform for patients | |
|
NEW |
or go to Amazon to order |
| Medical Doctors and Osteopathic Doctors, please contact info@biorica.biz for pricing information | |
| These statements have not been evaluated by the FDA. This product is not intended diagnose, cure or prevent any disease. |